UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Ipilimumab with Stereotactic Ablative Radiation Therapy: Phase I Results and Immunologic Correlates from Peripheral T Cells

Clinical cancer research, 2017-03, Vol.23 (6), p.1388-1396

2017

Volltextzugriff (PDF)

Circulating Tumor DNA Analysis in Patients With Cancer: American Society of Clinical Oncology and College of American Pathologists Joint Review

Journal of clinical oncology, 2018-06, Vol.36 (16), p.1631-1641

2018

Volltextzugriff (PDF)

Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer: A Joint Consensus Recommendation of the Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists

The Journal of molecular diagnostics : JMD, 2017-01, Vol.19 (1), p.4-23

2017

Volltextzugriff (PDF)

Personalized Medicine in a Phase I Clinical Trials Program: The MD Anderson Cancer Center Initiative

Clinical cancer research, 2012-11, Vol.18 (22), p.6373-6383

2012

Volltextzugriff (PDF)

Liquid Biopsies Using Plasma Exosomal Nucleic Acids and Plasma Cell-Free DNA Compared with Clinical Outcomes of Patients with Advanced Cancers

Clinical cancer research, 2018-01, Vol.24 (1), p.181-188

2018

Volltextzugriff (PDF)

Cancer Therapy Directed by Comprehensive Genomic Profiling: A Single Center Study

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (13), p.3690-3701

2016

Volltextzugriff (PDF)

Richter syndrome: Biology, incidence, and therapeutic strategies

Cancer, 2005-01, Vol.103 (2), p.216-228

2005

Volltextzugriff (PDF)

PI3K/AKT/mTOR Inhibitors in Patients With Breast and Gynecologic Malignancies Harboring PIK3CA Mutations

Journal of clinical oncology, 2012-03, Vol.30 (8), p.777-782

2012

Volltextzugriff (PDF)

Genomic and transcriptomic profiling expands precision cancer medicine: the WINTHER trial

Nature Medicine, 2019-05, Vol.25 (5), p.751-758

2019

Volltextzugriff (PDF)

Molecular tumour boards — current and future considerations for precision oncology

Nature reviews. Clinical oncology, 2023-12, Vol.20 (12), p.843-863

2023

Volltextzugriff (PDF)

Complex I inhibitor of oxidative phosphorylation in advanced solid tumors and acute myeloid leukemia: phase I trials

Nature medicine, 2023-01, Vol.29 (1), p.115-126

2023

Volltextzugriff (PDF)

PIK3CA Mutation H1047R Is Associated with Response to PI3K/AKT/mTOR Signaling Pathway Inhibitors in Early-Phase Clinical Trials

Cancer research (Chicago, Ill.), 2013-01, Vol.73 (1), p.276-284

2013

Volltextzugriff (PDF)

Personalized medicine for patients with advanced cancer in the phase I program at MD Anderson: validation and landmark analyses

Clinical cancer research, 2014-09, Vol.20 (18), p.4827-4836

2014

Volltextzugriff (PDF)

Health policy: Strategies to optimize expedited investigational new drug safety reports

Nature reviews. Clinical oncology, 2016-04, Vol.13 (4), p.207-208

Tsimberidou, Apostolia M

2016

Volltextzugriff (PDF)

Strategies to optimize expedited investigational new drug safety reports

Nature reviews. Clinical oncology, 2016-04, Vol.13 (4), p.207-208

Tsimberidou, Apostolia M.

2016

Volltextzugriff (PDF)

Multicenter Phase II Trial of the WEE1 Inhibitor Adavosertib in Refractory Solid Tumors Harboring CCNE1 Amplification

Journal of clinical oncology, 2023-03, Vol.41 (9), p.1725-1734

2023

Volltextzugriff (PDF)

Other Malignancies in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Journal of clinical oncology, 2009-02, Vol.27 (6), p.904-910

2009

Volltextzugriff (PDF)

Myeloid sarcoma is associated with superior event‐free survival and overall survival compared with acute myeloid leukemia

Cancer, 2008-09, Vol.113 (6), p.1370-1378

2008

Volltextzugriff (PDF)

Survival of 1,181 patients in a phase I clinic: the MD Anderson Clinical Center for targeted therapy experience

Clinical cancer research, 2012-05, Vol.18 (10), p.2922-2929

2012

Volltextzugriff (PDF)

Chemoimmunotherapy may overcome the adverse prognostic significance of 11q deletion in previously untreated patients with chronic lymphocytic leukemia

Cancer, 2009-01, Vol.115 (2), p.373-380

2009

Volltextzugriff (PDF)

Preclinical Development and First-in-Human Study of KA2507, a Selective and Potent Inhibitor of Histone Deacetylase 6, for Patients with Refractory Solid Tumors

Clinical cancer research, 2021-07, Vol.27 (13), p.3584-3594

2021

Volltextzugriff (PDF)

Ultimate Fate of Oncology Drugs Approved by the US Food and Drug Administration Without a Randomized Trial

Journal of clinical oncology, 2009-12, Vol.27 (36), p.6243-6250

2009

Volltextzugriff (PDF)

Analysis of 1,115 patients tested for MET amplification and therapy response in the MD Anderson Phase I Clinic

Clinical cancer research, 2014-12, Vol.20 (24), p.6336-6345

2014

Volltextzugriff (PDF)

Recommendations for Cell-Free DNA Assay Validations: A Joint Consensus Recommendation of the Association for Molecular Pathology and College of American Pathologists

The Journal of molecular diagnostics : JMD, 2023-12, Vol.25 (12), p.876-897

2023

Volltextzugriff (PDF)

1 – 25 von 282

Suche als RSS-Feed

Aktive Filter

KollektionNUS Single-Journal Subscriptions

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(282)
Mit Volltextzugriff
(264)

Publikationsform

Artikel
(282)

Sprache

Englisch
(282)
Japanisch
(13)

Erscheinungsjahr

n.n

Thema

Humans
(68)
Life Sciences & Biomedicine
(68)
Science & Technology
(68)
Oncology
(59)
Middle Aged
(50)
Female
(48)
Adult
(44)
Aged
(44)
Male
(44)
Biological And Medical Sciences
(39)
Medical Sciences
(39)
Tumors
(34)
Treatment Outcome
(27)
Aged, 80 And Over
(24)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(21)
Hematologic And Hematopoietic Diseases
(18)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(18)
Prognosis
(16)
Adolescent
(14)
Antineoplastic Agents - Therapeutic Use
(14)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(10)

Menü

Weitere Dienste

Einstellungen

Ipilimumab with Stereotactic Ablative Radiation Therapy: Phase I Results and Immunologic Correlates from Peripheral T Cells

Circulating Tumor DNA Analysis in Patients With Cancer: American Society of Clinical Oncology and College of American Pathologists Joint Review

Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer: A Joint Consensus Recommendation of the Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists

Personalized Medicine in a Phase I Clinical Trials Program: The MD Anderson Cancer Center Initiative

Liquid Biopsies Using Plasma Exosomal Nucleic Acids and Plasma Cell-Free DNA Compared with Clinical Outcomes of Patients with Advanced Cancers

Cancer Therapy Directed by Comprehensive Genomic Profiling: A Single Center Study

Richter syndrome: Biology, incidence, and therapeutic strategies

PI3K/AKT/mTOR Inhibitors in Patients With Breast and Gynecologic Malignancies Harboring PIK3CA Mutations

Genomic and transcriptomic profiling expands precision cancer medicine: the WINTHER trial

Molecular tumour boards — current and future considerations for precision oncology

Complex I inhibitor of oxidative phosphorylation in advanced solid tumors and acute myeloid leukemia: phase I trials

PIK3CA Mutation H1047R Is Associated with Response to PI3K/AKT/mTOR Signaling Pathway Inhibitors in Early-Phase Clinical Trials

Personalized medicine for patients with advanced cancer in the phase I program at MD Anderson: validation and landmark analyses

Health policy: Strategies to optimize expedited investigational new drug safety reports

Strategies to optimize expedited investigational new drug safety reports

Mutation-Enrichment Next-Generation Sequencing for Quantitative Detection of KRAS Mutations in Urine Cell-Free DNA from Patients with Advanced Cancers

Multicenter Phase II Trial of the WEE1 Inhibitor Adavosertib in Refractory Solid Tumors Harboring CCNE1 Amplification

Other Malignancies in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Myeloid sarcoma is associated with superior event‐free survival and overall survival compared with acute myeloid leukemia

Survival of 1,181 patients in a phase I clinic: the MD Anderson Clinical Center for targeted therapy experience

Chemoimmunotherapy may overcome the adverse prognostic significance of 11q deletion in previously untreated patients with chronic lymphocytic leukemia

Preclinical Development and First-in-Human Study of KA2507, a Selective and Potent Inhibitor of Histone Deacetylase 6, for Patients with Refractory Solid Tumors

Ultimate Fate of Oncology Drugs Approved by the US Food and Drug Administration Without a Randomized Trial

Analysis of 1,115 patients tested for MET amplification and therapy response in the MD Anderson Phase I Clinic

Recommendations for Cell-Free DNA Assay Validations: A Joint Consensus Recommendation of the Association for Molecular Pathology and College of American Pathologists

Aktive Filter

Suchergebnisse filtern